Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 13, 2020

SELL
$48.0 - $59.55 $27.6 Million - $34.3 Million
-575,847 Closed
0 $0
Q3 2019

Nov 13, 2019

SELL
$46.64 - $55.39 $56.9 Million - $67.6 Million
-1,220,928 Reduced 67.95%
575,847 $30.6 Million
Q2 2019

Aug 14, 2019

SELL
$40.81 - $52.42 $17.2 Million - $22.1 Million
-422,299 Reduced 19.03%
1,796,775 $91.8 Million
Q1 2019

May 15, 2019

BUY
$36.91 - $55.7 $17.1 Million - $25.8 Million
462,724 Added 26.35%
2,219,074 $115 Million
Q4 2018

Feb 14, 2019

SELL
$36.49 - $51.72 $1.74 Million - $2.47 Million
-47,754 Reduced 2.65%
1,756,350 $69.1 Million
Q3 2018

Nov 14, 2018

BUY
$46.5 - $53.55 $1.46 Million - $1.68 Million
31,323 Added 1.77%
1,804,104 $93 Million
Q2 2018

Aug 14, 2018

SELL
$35.0 - $48.9 $5.35 Million - $7.47 Million
-152,767 Reduced 7.93%
1,772,781 $83.1 Million
Q1 2018

May 15, 2018

BUY
$31.7 - $44.1 $61 Million - $84.9 Million
1,925,548 New
1,925,548 $68.4 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Viking Global Investors LP Portfolio

Follow Viking Global Investors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Viking Global Investors LP, based on Form 13F filings with the SEC.

News

Stay updated on Viking Global Investors LP with notifications on news.